跳至主要内容
临床试验/CTRI/2025/03/082005
CTRI/2025/03/082005尚未招募3 期

Randomised comparative clinical study to evaluate the efficacy of vachadi gana churna and haridradi gana churna in the management of medoroga w.s.r. to dyslipidemia

Madan mohan malviya government ayurved college udaipur1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年4月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Relief in sign and symptoms

研究概览

简要总结

RANDOMISED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VACHADI GANA CHURNA AND HARIDRADI GANA CHURNA IN THE MANAGEMENT OF MEDOROGA W.S.R. TO DYSLIPIDEMIA

There will be two group in the study.

In Group A randomly selected and clinically diagnosed 30 patient of Medoroga will be given Vachadi gana churna twice a day before meal.

In Group B randomly selected and clinically diagnosed 30 patient of Medoroga will be given Haridradi gana churna twice a day before meal.

Both trial will be conduct for a period of 2 months.

Follow up of the case will be after 15 days that is four time during treatment.

Final assesment will be done after completion of two month course on the basis of subjective and laborateral assesment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • INCLUSION CRITERIA 1.Patients between the age group of 20 to 70 years of either both of sex.
  • 2.Diagnosed cases of Dyslipidemia & Medoroga on the basis of criteria given by NCEP ATP3 (Serum Cholesterol equal or more than 200 mg/dl, Serum Triglycerides equal or more than 150mg/dl, LDL Cholesterol equal or more than 130mg/dl, HDL Cholesterol less than 40mg/dl), Any one of these.
  • 3.Willing and able to participate in the study for 2 months.
  • 4.Patients having lakshana of Medoroga as described in Madhava Nidana.

排除标准

  • 1.Patients having medical history of a.Unstable Angina, Myocardial Infarction, Uncontrolled Hypertension (Diastolic Blood Pressure more than 100 mmHg), Uncontrolled Diabetes Mellitus etc.
  • b.Impaired Renal Function (Creatinine equal or more than 2 mg /dl) c.ALT and AST more than 2 times of upper limit of normal.
  • d.Patients with evidence of malignancy.
  • e.Pregnancy, Lactation and patients having dyslipidemia due to drugs e.g. glucocorticoids, diuretics.

结局指标

主要结局

Relief in sign and symptoms

时间窗: 60 days

次要结局

  • Hemoglobin (gm%), ESR, Serum total cholesterol, serum triglycerides, LDL, VLDL & HDL level will be analysed.(60 days)

研究者

发起方
Madan mohan malviya government ayurved college udaipur
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Monika mahawar

Madan mohan malviya government ayurved college udaipur

研究点 (1)

Loading locations...

相似试验

To compare the effect of vachadi gana churna and... | 临床试验